Cargando…
The Clinical Burden of Clostridioides difficile in Ontario, Canada
BACKGROUND: To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the community, or ACH-associated with community-onse...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993863/ https://www.ncbi.nlm.nih.gov/pubmed/32025524 http://dx.doi.org/10.1093/ofid/ofz523 |
_version_ | 1783493116903292928 |
---|---|
author | Pereira, Jennifer A McGeer, Allison Tomovici, Antigona Selmani, Alex Chit, Ayman |
author_facet | Pereira, Jennifer A McGeer, Allison Tomovici, Antigona Selmani, Alex Chit, Ayman |
author_sort | Pereira, Jennifer A |
collection | PubMed |
description | BACKGROUND: To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the community, or ACH-associated with community-onset. METHODS: We performed a retrospective analysis using individual-level data from Ontario databases (April 1, 2005 to March 31, 2015), identifying CDI cases ≥18 years requiring hospitalization, and stratifying into cohorts based on association and onset location. Cohort members were matched to controls on demographics and medical conditions at onset, for outcomes including 30- and 180-day all-cause mortality and rehospitalization. RESULTS: We stratified 22 617 individuals hospitalized with CDI during the study period: 13 152 (58.1%) ACH-associated/ACH-onset, 7116 (31.5%) community-associated/community-onset, 1847 (8.2%) ACH-associated/community-onset, and 502 (2.2%) LTCF-associated/LTCF-onset. Compared with controls, unadjusted 30-day rehospitalization rates were significantly higher (P < .0001) for ACH-associated/ACH-onset CDI (9.5% vs 0.4%), LTCF-associated/LTCF-onset (7.2% vs 1.1%), community-associated/community-onset (7.8% vs 0.8%), and ACH-associated/community-onset (10.9% vs 0.7%). One hundred eighty-day mortality rates were higher in the community-associated/community-onset and the LTCF-associated/LTCF-onset cohorts than controls: 66.3% vs 12.3% (P < .0001) and 30.9% vs 3.1% (P < .0001), respectively. All differences remained significant after adjusting for patient factors. CONCLUSIONS: Clostridioides difficile infection is associated with higher rates of 30-day rehospitalization compared with controls. In addition, mortality rates within 180-days of hospital discharge are significantly higher for community-associated/community-onset and LTCF-associated/LTCF-onset CDI cohorts than controls. Clostridioides difficile infection warrants increased prevention and monitoring efforts. |
format | Online Article Text |
id | pubmed-6993863 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-69938632020-02-05 The Clinical Burden of Clostridioides difficile in Ontario, Canada Pereira, Jennifer A McGeer, Allison Tomovici, Antigona Selmani, Alex Chit, Ayman Open Forum Infect Dis Major Article BACKGROUND: To understand the clinical burden of Clostridioides difficile infection (CDI), we analyzed health outcome data from Ontario, Canada for CDI associated with and manifested in acute care hospitals (ACH), long-term care facilities (LTCF), the community, or ACH-associated with community-onset. METHODS: We performed a retrospective analysis using individual-level data from Ontario databases (April 1, 2005 to March 31, 2015), identifying CDI cases ≥18 years requiring hospitalization, and stratifying into cohorts based on association and onset location. Cohort members were matched to controls on demographics and medical conditions at onset, for outcomes including 30- and 180-day all-cause mortality and rehospitalization. RESULTS: We stratified 22 617 individuals hospitalized with CDI during the study period: 13 152 (58.1%) ACH-associated/ACH-onset, 7116 (31.5%) community-associated/community-onset, 1847 (8.2%) ACH-associated/community-onset, and 502 (2.2%) LTCF-associated/LTCF-onset. Compared with controls, unadjusted 30-day rehospitalization rates were significantly higher (P < .0001) for ACH-associated/ACH-onset CDI (9.5% vs 0.4%), LTCF-associated/LTCF-onset (7.2% vs 1.1%), community-associated/community-onset (7.8% vs 0.8%), and ACH-associated/community-onset (10.9% vs 0.7%). One hundred eighty-day mortality rates were higher in the community-associated/community-onset and the LTCF-associated/LTCF-onset cohorts than controls: 66.3% vs 12.3% (P < .0001) and 30.9% vs 3.1% (P < .0001), respectively. All differences remained significant after adjusting for patient factors. CONCLUSIONS: Clostridioides difficile infection is associated with higher rates of 30-day rehospitalization compared with controls. In addition, mortality rates within 180-days of hospital discharge are significantly higher for community-associated/community-onset and LTCF-associated/LTCF-onset CDI cohorts than controls. Clostridioides difficile infection warrants increased prevention and monitoring efforts. Oxford University Press 2019-12-14 /pmc/articles/PMC6993863/ /pubmed/32025524 http://dx.doi.org/10.1093/ofid/ofz523 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Pereira, Jennifer A McGeer, Allison Tomovici, Antigona Selmani, Alex Chit, Ayman The Clinical Burden of Clostridioides difficile in Ontario, Canada |
title | The Clinical Burden of Clostridioides difficile in Ontario, Canada |
title_full | The Clinical Burden of Clostridioides difficile in Ontario, Canada |
title_fullStr | The Clinical Burden of Clostridioides difficile in Ontario, Canada |
title_full_unstemmed | The Clinical Burden of Clostridioides difficile in Ontario, Canada |
title_short | The Clinical Burden of Clostridioides difficile in Ontario, Canada |
title_sort | clinical burden of clostridioides difficile in ontario, canada |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993863/ https://www.ncbi.nlm.nih.gov/pubmed/32025524 http://dx.doi.org/10.1093/ofid/ofz523 |
work_keys_str_mv | AT pereirajennifera theclinicalburdenofclostridioidesdifficileinontariocanada AT mcgeerallison theclinicalburdenofclostridioidesdifficileinontariocanada AT tomoviciantigona theclinicalburdenofclostridioidesdifficileinontariocanada AT selmanialex theclinicalburdenofclostridioidesdifficileinontariocanada AT chitayman theclinicalburdenofclostridioidesdifficileinontariocanada AT pereirajennifera clinicalburdenofclostridioidesdifficileinontariocanada AT mcgeerallison clinicalburdenofclostridioidesdifficileinontariocanada AT tomoviciantigona clinicalburdenofclostridioidesdifficileinontariocanada AT selmanialex clinicalburdenofclostridioidesdifficileinontariocanada AT chitayman clinicalburdenofclostridioidesdifficileinontariocanada |